"In a major change of strategy, the new head of GlaxoSmithKline, Andrew Witty, has told the Guardian he will slash prices on all medicines in the poorest countries, give back profits to be spent on hospitals and clinics and – most ground-breaking of all – share knowledge about potential drugs that are currently protected by patents."
via gaurdian.co.uk
Hope for the Poor
Posted by : m
on 2/23/2009 |
0 Comments
Labels:
news
|
This entry was posted on 2/23/2009
and is filed under
news
.
You can follow any responses to this entry through
the RSS 2.0 feed.
You can leave a response,
or trackback from your own site.
Subscribe to:
Post Comments (Atom)
Posts
0 comments:
Post a Comment